Navigation Links
IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial

new cases are expected to be diagnosed and it is estimated that approximately 8,110 people in the United Sates will die from the disease.

About IDM Pharma

IDM Pharma (IDM) is a biopharmaceutical company focused on the development of innovative products that activate the immune system to treat cancer. IDM's lead product candidate, JUNOVAN(TM) (mifamurtide for injection), known as MEPACT in Europe, is part of a new family of immunotherapeutic agents designed to destroy residual cancer cells by activating the body's natural defenses. IDM's applications requesting marketing approval of JUNOVAN for use in the treatment of newly diagnosed resectable high-grade osteosarcoma patients in combination with multiple agent chemotherapy are under review by the U.S. Food and Drug Administration, or FDA, in the United States and by the European Medicines Agency, or EMEA, in Europe. IDM is jointly developing UVIDEM, a cell-based vaccine product candidate in Phase II clinical trials for the treatment of melanoma, with sanofi-aventis. EP-2101 is currently being tested in non-small cell lung cancer (NSCLC) patients in a Phase II clinical trial and is composed of multiple tumor-specific CTL epitopes selected from tumor- associated antigens.

For more information, visit http://www.idm-pharma.com.

About sanofi-aventis

Sanofi-aventis is one of the world leaders in the pharmaceutical industry, ranking number one in Europe. Backed by a world-class R&D organization, sanofi-aventis is developing leading positions in seven major therapeutic areas: cardiovascular, thrombosis, oncology, metabolic diseases, central nervous system, internal medicine and vaccines. Sanofi-aventis is listed in Paris and in New York .

Forward-Looking Statements

This press release includes and the presentation described in this press release will include forward-looking statements that reflect management's curr
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Sygnis Pharma AG announces date for presentation of clinical results
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment

Post Your Comments:
(Date:11/27/2009)..., Nov. 27 ACUO TECHNOLOGIES, devel... software, data migration tools and services, is p...nd Trademark Office has approved a patent applicat...mputer Network." Acuo Technologies is pleased to a...l property. In general, the granted patent applica...
(Date:11/26/2009)..., South Africa, Nov. 26 The 2009 F...ar Award in the Generic Pharmaceutical Market is p..., (Logo: http://www.newscom.com/cgi-bin/prnh/200...ward, the following criteria were used to benchmar...rs: growth strategy and implementation, degree of ...
(Date:11/25/2009)..., Nov. 25 American Sci...ompany") is pleased to announce that they have ope... office in Shanghai, China. ,, ASR has been abl...ial gateway for the development and production of ...children and adults to be distributed and sold glo...
Breaking Medicine Technology:Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4American Scientific Resources Inc. Opens Shanghai Location 2Cytopia Merger with Toronto based YM BioSciences Inc 14360 1Cytopia Merger with Toronto based YM BioSciences Inc 14360 2Cytopia Merger with Toronto based YM BioSciences Inc 14360 3Cytopia Merger with Toronto based YM BioSciences Inc 14360 4Cytopia Merger with Toronto based YM BioSciences Inc 14360 5Cytopia Merger with Toronto based YM BioSciences Inc 14360 6Cytopia Merger with Toronto based YM BioSciences Inc 14360 7Deputy Secretary Gould Talks Strategies for Federal Performance 58901 1Deputy Secretary Gould Talks Strategies for Federal Performance 58901 2Boston Scientific Announces Exclusive Sponsorship and First Enrollments of MADIT RIT Clinical Trial 14358 1Boston Scientific Announces Exclusive Sponsorship and First Enrollments of MADIT RIT Clinical Trial 14358 2Boston Scientific Announces Exclusive Sponsorship and First Enrollments of MADIT RIT Clinical Trial 14358 3
...a., May 4 EPSScentral LLC today announced its rea...unicating, and implementing mitigation measures in...nfluenza A crisis. According to the WHO, phase 5 ...t and that the time to finalize... mitigation meas....com/cgi-bin/prnh/20080701/DC26612LOGO ) , , A ...
...erience Significant Improvement in Ocular Surface ....J., May 4 Aton Pharma, Inc. announced today that...nt registry study of its Lacrisert(R) ophthalmic i...Annual Meeting of the Association for Research in ...erdale, FL, and later in the month at the 145th An...
Other Medicine Technology:EPSScentral Responds to Pandemic Alert 2ARVO, AOS: Large Study of Lacrisert(R) Dry Eye Insert; 2ARVO, AOS: Large Study of Lacrisert(R) Dry Eye Insert; 3ARVO, AOS: Large Study of Lacrisert(R) Dry Eye Insert; 4ARVO, AOS: Large Study of Lacrisert(R) Dry Eye Insert; 5
(Date:11/28/2009)...ov. 28 Welcome to syngo® ... clinical routine from Siemens Healthcare. As ...ystem (PACS) from Siemens where 2D, 3D, and 4D r...za is poised to change the way multimodality image...tion at the 95th Scientific Assembly and Annual ...
(Date:11/28/2009)...lp lift spirits, recognize signs of depression , ...or many seniors, the holiday season can trigger me...ggle with health issues or worry about money probl... , To help overcome the seasonal blues, the AGS...ng advice: , Get out and socialize or invite fam...
(Date:11/27/2009)... 27 Considered a highly... years ago, solid organ transplantation is now a l...aordinary men and women who gathered at the Winspe...together from medical centers around the world to ...Transplant Institute (BRTI), one of the pioneers o...
(Date:11/27/2009)...R, Israel, Nov. 27 Shami..." ), a leading provider of innovative products and...ed today that its board of directors had declared ...US$ 10 million (approximately NIS 37.62 million ba...f exchange), or approximately US$ 0.609 (approxima...
(Date:11/27/2009)..., SEATTLE, Nov. 27 Allrecipes.c...igh Thanksgiving traffic numbers, with more than 2...roviding a clear picture of what was served on the...nksgiving meal in 2009 weighed in at 2,225 calorie...,s feast. According to the Allrecipes site, Sweet...
Breaking Medicine News(10 mins):Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 2Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 3Health News:Seniors May Need Help Overcoming Holiday Blues 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4
...n a visionary move the veterinary schools in sub-S...rnet-based training programme that will allow vets...ing to work. The African Universities Veterina...ence-for-development network. African vets ur...
...uck Owens, the King of country music and the perso... States with a string of 1960s hits and a long-run... Owens' family said he died in his sleep at his ho...Born Aug 12, 1929, in Texas to a poor farming fami...
...ith an eye on the job market, India's premier scho... year Japanese as an optional language course from...ard of Secondary Education (CBSE), the move will h...and gain a better understanding of other cultures,...
...aghuvansh Prasad Singh, the Rural Development Mini... was set to achieve open defecation free status un...( TSC) by 2012. Open defecation is a problem...on in the poor as well as rural communities has re...
...wo of the most promising breast cancer drugs are r...who revealed their findings// at he European Breas... that was first developed to treat osteoporosis in...ce it's use in breast cancer. In the trials where ...
... teenage boy, badly hurt in a farm accident, claim... a Helicopter//. The 16 year old teenage boy...d was lifted by a PSNI helicopter. Insp Roger McCo... were on the scene all deserve praise. But we cert...
Other Medicine News:Health News:Schools set to offer Japanese language course 2Health News:India On The Road To Become 'Open Defecation Free' 2
Force EZ Electrosurgical Generator
Black Multi-Pinhole Occluder
49 Pinhole short handle
Frosted Long Handle Occluder
Medicine Products: